Feb 4 (Reuters)-
Zeria Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2019 Dec 31, 2018 Mar 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 46.30 47.22 65.00
(-1.9 pct) (-4.9 pct) (+5.1 pct)
Operating 3.38 3.06 5.00
(+10.5 pct) (-33.3 pct) (+33.8 pct)
Recurring 3.09 2.82 5.00
(+9.5 pct) (-42.3 pct) (+51.7 pct)
Net 2.34 2.90 3.80
(-19.3 pct) (-26.7 pct) (+10.0 pct)
EPS 49.98 yen 57.96 yen 81.34 yen
Ann Div 34.00 yen 34.00 yen
-Q2 div 17.00 yen 17.00 yen
-Q4 div 17.00 yen 17.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T